Literature DB >> 12361237

Combination of antibiotic mechanisms in lantibiotics.

Anja Hoffmann1, Ulrike Pag, Imke Wiedemann, Hans-Georg Sahl.   

Abstract

Recent studies on the mode of action have revealed exciting features of multiple activities of nisin and related lantibiotics making these peptides interesting model systems for the design of new antibiotics (Molec. Microbiol. 30 (1998) 317; Science 286 (1999) 2361; J. Biol. Chem. 276 (2001) 1772.). In contrast to other groups of antibiotic peptides, the lantibiotics display a substantial degree of specificity for particular components of bacterial membranes. Mersacidin and actagardine were shown to bind with high affinity to the lipid coupled peptidoglycan precursor, the so-called lipid II, which prevents the polymerisation of the cell wall monomers into a functional murein sacculus. The lantibiotics nisin and epidermin also bind tightly to this cell wall precursor; however, for these lantibiotics the binding of lipid II has two consequences. Like with mersacidin blocking of lipid II inhibits peptidoglycan biosynthesis; in addition, lipid II is used as a specific docking molecule for the formation of pores. This combination of lethal effects explains the potency of these peptides, which are active in nanomolar concentration. Other type-A lantibiotics are believed to also use docking molecules for pore formation, although identification of such membrane components has not yet been achieved.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12361237     DOI: 10.1016/s0014-827x(02)01208-9

Source DB:  PubMed          Journal:  Farmaco        ISSN: 0014-827X


  9 in total

1.  A central composite rotatable design (CCRD) approach to study the combined effect of antimicrobial agents against bacterial pathogens.

Authors:  Fernanda Godoy Santos; Layanne Andrade Mendonça; Hilário Cuquetto Mantovani
Journal:  World J Microbiol Biotechnol       Date:  2015-06-17       Impact factor: 3.312

Review 2.  Intracellular Targeting Mechanisms by Antimicrobial Peptides.

Authors:  Cheng-Foh Le; Chee-Mun Fang; Shamala Devi Sekaran
Journal:  Antimicrob Agents Chemother       Date:  2017-03-24       Impact factor: 5.191

3.  Identification of a nisI promoter within the nisABCTIP operon that may enable establishment of nisin immunity prior to induction of the operon via signal transduction.

Authors:  Haiping Li; Daniel J O'Sullivan
Journal:  J Bacteriol       Date:  2006-09-29       Impact factor: 3.490

4.  Circumventing the effect of product toxicity: development of a novel two-stage production process for the lantibiotic gallidermin.

Authors:  G Valsesia; G Medaglia; M Held; W Minas; S Panke
Journal:  Appl Environ Microbiol       Date:  2006-12-28       Impact factor: 4.792

5.  Transcription analysis of a lantibiotic gene cluster from Bifidobacterium longum DJO10A.

Authors:  Ju-Hoon Lee; Xiulan Li; Daniel J O'Sullivan
Journal:  Appl Environ Microbiol       Date:  2011-07-08       Impact factor: 4.792

6.  Draft Whole-Genome Sequence of Bacillus sonorensis Strain L12, a Source of Nonribosomal Lipopeptides.

Authors:  David B Adimpong; Kim I Sørensen; Dennis S Nielsen; Line Thorsen; Thomas B Rasmussen; Patrick M F Derkx; Lene Jespersen
Journal:  Genome Announc       Date:  2013-03-28

7.  The lantibiotic mersacidin is a strong inducer of the cell wall stress response of Staphylococcus aureus.

Authors:  Peter Sass; Andrea Jansen; Christiane Szekat; Vera Sass; Hans-Georg Sahl; Gabriele Bierbaum
Journal:  BMC Microbiol       Date:  2008-10-23       Impact factor: 3.605

8.  Complete genome sequence of the industrial bacterium Bacillus licheniformis and comparisons with closely related Bacillus species.

Authors:  Michael W Rey; Preethi Ramaiya; Beth A Nelson; Shari D Brody-Karpin; Elizabeth J Zaretsky; Maria Tang; Alfredo Lopez de Leon; Henry Xiang; Veronica Gusti; Ib Groth Clausen; Peter B Olsen; Michael D Rasmussen; Jens T Andersen; Per L Jørgensen; Thomas S Larsen; Alexei Sorokin; Alexander Bolotin; Alla Lapidus; Nathalie Galleron; S Dusko Ehrlich; Randy M Berka
Journal:  Genome Biol       Date:  2004-09-13       Impact factor: 13.583

Review 9.  Bioengineering Lantibiotics for Therapeutic Success.

Authors:  Des Field; Paul D Cotter; Colin Hill; R P Ross
Journal:  Front Microbiol       Date:  2015-11-27       Impact factor: 5.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.